This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.
This website is part of the project ’826652 Euripid’ which is co-funded by the European Union’s Health Programme (2014-2020).
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
Pharmaceutical Strategy for Europe
/in News /by Betty TestAdopted on 25 November 2020, the Pharmaceutical Strategy for Europe aims at creating a future proof regulatory framework and at supporting industry in promoting research and technologies that actually reach patients in order to fulfil their therapeutic needs while addressing market failures. Read more
WHO Fair Pricing Forum 2021
/in News /by Betty TestThe 3rd Fair Pricing Forum took place online from 13-22 April 2021 and focused again on improving access to medicines and health products through fair pricing, following the inaugural forum held in the Netherlands in 2017 (10–11 May) and the second forum in South Africa in 2019 (11-13 April). WHO invited the Euripid Collaboration to present […]
EURIPID survey – Sharing information about confidential agreements
/in News /by Janos MuzsiIn the light of the WHA resolution in 2019 on improving transparency in the medicines’ market, the EURIPID Executive Committee launched a survey to explore feasible options to foster information exchange and cross-country collaboration in this field. The survey focused on high-cost and on-patent medicines, for which the sharing of price information is potentially more […]